business

Citi picks top pharma stocks; positive on Ranbaxy, Lupin

In an interview with CNBC-TV18, Prashant Nair, Director & Deputy Head of Research, Citi India gives his outlook on the pharma sector. He picks Ranbaxy, Lupin, Apollo Hospital and Ipca as preferred stocks and believes, they will outperform not just the market but also its peers from the pharma space.

first published: May 31, 2012 02:21 pm